IL-6 appears to be decisively involved in the development of IR and GDM, primarily by the impaired phosphorylation of the insulin receptors and the induced expression of SOCS3, which inhibits the insulin signaling in peripheral tissues, adipocytes and hepatocytes [266]. Here, IL6 is linked to gestational diabetes.